TY - JOUR
T1 - The effect of dopaminergic medication on beat-based auditory timing in Parkinson's disease
AU - Cameron, Daniel J.
AU - Pickett, Kristen A.
AU - Earhart, Gammon M.
AU - Grahn, Jessica A.
N1 - Funding Information:
This work was supported by a grant from the Parkinson Society Canada to JG and NIH grant R01NS077959 to GE. additional support was provided by the Greater St. Louis American Parkinson Disease Association (APDA) and the APDA Center for Advanced Research at Washington University in St. Louis. The authors would like to acknowledge and thank Esther Lachance, Ryan Duncan, Martha Hessler, Rich Nagel, and Marie McNeely for their help testing participants.
Publisher Copyright:
© 2016 Cameron, Pickett, Earhart and Grahn.
PY - 2016/2/22
Y1 - 2016/2/22
N2 - Parkinson's disease (PD) adversely affects timing abilities. Beat-based timing is a mechanism that times events relative to a regular interval, such as the "beat" in musical rhythm, and is impaired in PD. It is unknown if dopaminergic medication influences beat-based timing in PD. Here, we tested beat-based timing over two sessions in participants with PD (OFF then ON dopaminergic medication) and in unmedicated control participants. People with PD and control participants completed two tasks. The first was a discrimination task in which participants compared two rhythms and determined whether they were the same or different. Rhythms either had a beat structure (metric simple rhythms) or did not (metric complex rhythms), as in previous studies. Discrimination accuracy was analyzed to test for the effects of beat structure, as well as differences between participants with PD and controls, and effects of medication (PD group only). The second task was the Beat Alignment Test (BAT), in which participants listened to music with regular tones superimposed, and responded as to whether the tones were "ON" or "OFF" the beat of the music. Accuracy was analyzed to test for differences between participants with PD and controls, and for an effect of medication in patients. Both patients and controls discriminated metric simple rhythms better than metric complex rhythms. Controls also improved at the discrimination task in the second vs. first session, whereas people with PD did not. For participants with PD, the difference in performance between metric simple and metric complex rhythms was greater (sensitivity to changes in simple rhythms increased and sensitivity to changes in complex rhythms decreased) when ON vs. OFF medication. Performance also worsened with disease severity. For the BAT, no group differences or effects of medication were found. Overall, these findings suggest that timing is impaired in PD, and that dopaminergic medication influences beat-based and non-beat-based timing differently. Judging the beat in music does not appear to be affected by PD or by dopaminergic medication.
AB - Parkinson's disease (PD) adversely affects timing abilities. Beat-based timing is a mechanism that times events relative to a regular interval, such as the "beat" in musical rhythm, and is impaired in PD. It is unknown if dopaminergic medication influences beat-based timing in PD. Here, we tested beat-based timing over two sessions in participants with PD (OFF then ON dopaminergic medication) and in unmedicated control participants. People with PD and control participants completed two tasks. The first was a discrimination task in which participants compared two rhythms and determined whether they were the same or different. Rhythms either had a beat structure (metric simple rhythms) or did not (metric complex rhythms), as in previous studies. Discrimination accuracy was analyzed to test for the effects of beat structure, as well as differences between participants with PD and controls, and effects of medication (PD group only). The second task was the Beat Alignment Test (BAT), in which participants listened to music with regular tones superimposed, and responded as to whether the tones were "ON" or "OFF" the beat of the music. Accuracy was analyzed to test for differences between participants with PD and controls, and for an effect of medication in patients. Both patients and controls discriminated metric simple rhythms better than metric complex rhythms. Controls also improved at the discrimination task in the second vs. first session, whereas people with PD did not. For participants with PD, the difference in performance between metric simple and metric complex rhythms was greater (sensitivity to changes in simple rhythms increased and sensitivity to changes in complex rhythms decreased) when ON vs. OFF medication. Performance also worsened with disease severity. For the BAT, no group differences or effects of medication were found. Overall, these findings suggest that timing is impaired in PD, and that dopaminergic medication influences beat-based and non-beat-based timing differently. Judging the beat in music does not appear to be affected by PD or by dopaminergic medication.
KW - Beat perception
KW - Dopamine
KW - Parkinson's disease
KW - Rhythm
KW - Timing
UR - http://www.scopus.com/inward/record.url?scp=84962003949&partnerID=8YFLogxK
U2 - 10.3389/fneur.2016.00019
DO - 10.3389/fneur.2016.00019
M3 - Article
C2 - 26941707
AN - SCOPUS:84962003949
SN - 1664-2295
VL - 7
JO - Frontiers in Neurology
JF - Frontiers in Neurology
IS - FEB
M1 - 19
ER -